1
|
Gimm O: Thyroid cancer. Cancer Lett.
163:143–156. 2001.PubMed/NCBI View Article : Google Scholar
|
2
|
Maia FF, Vassallo J, Pinto GA, Pavin EJ,
Matos PS and Zantut-Wittmann DE: Expression of Mcl-1 and Ki-67 in
papillary thyroid carcinomas. Exp Clin Endocrinol Diabetes.
124:209–214. 2016.PubMed/NCBI View Article : Google Scholar
|
3
|
Wen Q, Zhao L, Wang T, Lv N, Cheng X,
Zhang G and Bai L: LncRNA SNHG16 drives proliferation and invasion
of papillary thyroid cancer through modulation of miR-497. Onco
Targets Ther. 12:699–708. 2019.PubMed/NCBI View Article : Google Scholar
|
4
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004.PubMed/NCBI View Article : Google Scholar
|
5
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297.
2004.PubMed/NCBI View Article : Google Scholar
|
6
|
Feng B, Dong TT, Wang LL, Zhou HM, Zhao
HC, Dong F and Zheng MH: Colorectal cancer migration and invasion
initiated by microRNA-106a. PLoS One. 7(e43452)2012.PubMed/NCBI View Article : Google Scholar
|
7
|
Zhu Z, Yang Q, Zhang B, Wu W, Yuan F and
Zhu Z: miR-106b promotes metastasis of early gastric cancer by
targeting ALEX1 in vitro and in vivo. Cell Physiol Biochem.
52:606–616. 2019.PubMed/NCBI View Article : Google Scholar
|
8
|
Yin Y, Hong S, Yu S, Huang Y, Chen S, Liu
Y, Zhang Q, Li Y and Xiao H: MiR-195 inhibits tumor growth and
metastasis in papillary thyroid carcinoma cell lines by targeting
CCND1 and FGF2. Int J Endocrinol. 2017(6180425)2017.PubMed/NCBI View Article : Google Scholar
|
9
|
Wang D, Wang H, Li Y and Li Q: MiR-362-3p
functions as a tumor suppressor through targeting MCM5 in cervical
adenocarcinoma. Biosci Rep. 38(pii: BSR20180668)2018.PubMed/NCBI View Article : Google Scholar
|
10
|
Park YR, Seo SY, Kim SL, Zhu SM, Chun S,
Oh JM, Lee MR, Kim SH, Kim IH, Lee SO, et al: MiRNA-206 suppresses
PGE2-induced colorectal cancer cell proliferation, migration, and
invasion by targetting TM4SF1. Biosci Rep. 38:2018.pii:
BSR20180664. PubMed/NCBI View Article : Google Scholar
|
11
|
Minna E, Romeo P, Dugo M, De Cecco L,
Todoerti K, Pilotti S, Perrone F, Seregni E, Agnelli L, Neri A, et
al: miR-451a is underexpressed and targets AKT/mTOR pathway in
papillary thyroid carcinoma. Oncotarget. 7:12731–12747.
2016.PubMed/NCBI View Article : Google Scholar
|
12
|
Xia F, Wang W, Jiang B, Chen Y and Li X:
DNA methylation-mediated silencing of miR-204 is a potential
prognostic marker for papillary thyroid carcinoma. Cancer Manag
Res. 11:1249–1262. 2019.PubMed/NCBI View Article : Google Scholar
|
13
|
Chen H and Boutros PC: VennDiagram: A
package for the generation of highly-customizable Venn and Euler
diagrams in R. BMC Bioinformatics. 12(35)2011.PubMed/NCBI View Article : Google Scholar
|
14
|
Saiselet M, Gacquer D, Spinette A, Craciun
L, Decaussin-Petrucci M, Andry G, Detours V and Maenhaut C: New
global analysis of the microRNA transcriptome of primary tumors and
lymph node metastases of papillary thyroid cancer. BMC Genomics.
16(828)2015.PubMed/NCBI View Article : Google Scholar
|
15
|
Sticht C, De La Torre C, Parveen A and
Gretz N: miRWalk: An online resource for prediction of microRNA
binding sites. PLoS One. 13(e0206239)2018.PubMed/NCBI View Article : Google Scholar
|
16
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003.PubMed/NCBI View Article : Google Scholar
|
17
|
Yu G, Wang LG, Han Y and He QY:
clusterProfiler: An R package for comparing biological themes among
gene clusters. OMICS. 16:284–287. 2012.PubMed/NCBI View Article : Google Scholar
|
18
|
Gao X, Wang J and Zhang S: Integrated
bioinformatics analysis of hub genes and pathways in anaplastic
thyroid carcinomas. Int J Endocrinol. 2019(9651380)2019.PubMed/NCBI View Article : Google Scholar
|
19
|
Gao X, Wang X and Zhang S: Bioinformatics
identification of crucial genes and pathways associated with
hepatocellular carcinoma. Biosci Rep. 38(pii:
BSR20181441)2018.PubMed/NCBI View Article : Google Scholar
|
20
|
Zhang S, Wang Q, Han Q, Han H and Lu P:
Identification and analysis of genes associated with papillary
thyroid carcinoma by bioinformatics methods. Biosci Rep. 39(pii:
BSR20190083)2019.PubMed/NCBI View Article : Google Scholar
|
21
|
Jia M, Shi Y, Li Z, Lu X and Wang J:
MicroRNA-146b-5p as an oncomiR promotes papillary thyroid carcinoma
development by targeting CCDC6. Cancer Lett. 443:145–156.
2019.PubMed/NCBI View Article : Google Scholar
|
22
|
Zhang XF, Ye Y and Zhao SJ: LncRNA Gas5
acts as a ceRNA to regulate PTEN expression by sponging miR-222-3p
in papillary thyroid carcinoma. Oncotarget. 9:3519–3530.
2017.PubMed/NCBI View Article : Google Scholar
|
23
|
Jiang L, Wu Z, Meng X, Chu X, Huang H and
Xu C: LncRNA HOXA-AS2 facilitates tumorigenesis and progression of
papillary thyroid cancer by modulating the miR-15a-5p/HOXA3 axis.
Hum Gene Ther. 30:618–631. 2019.PubMed/NCBI View Article : Google Scholar
|
24
|
Zhang H, Cai Y, Zheng L, Zhang Z, Lin X
and Jiang N: LncRNA BISPR promotes the progression of thyroid
papillary carcinoma by regulating miR-21-5p. Int J Immunopathol
Pharmacol.
32(2058738418772652)2018.https://doi.org/10.1177/2058738418772652.
PubMed/NCBI View Article : Google Scholar
|
25
|
Swierniak M, Wojcicka A, Czetwertynska M,
Stachlewska E, Maciag M, Wiechno W, Gornicka B, Bogdanska M,
Koperski L, de la Chapelle A, et al: In-depth characterization of
the microRNA transcriptome in normal thyroid and papillary thyroid
carcinoma. J Clin Endocrinol Metab. 98:E1401–1409. 2013.PubMed/NCBI View Article : Google Scholar
|
26
|
Chen S, Fan X, Gu H, Zhang L and Zhao W:
Competing endogenous RNA regulatory network in papillary thyroid
carcinoma. Mol Med Rep. 18:695–704. 2018.PubMed/NCBI View Article : Google Scholar
|